C12Y 304/24011
Neprilysin , i.e. enkephalinase or neutral endopeptidase 24.11
Official title: Neprilysin (3.4.24.11), i.e. enkephalinase or neutral endopeptidase 24.11
C12Y304/24011 (Neprilysin , i.e. enkephalinase or neutral endopeptidase 24.11) appears on 19 US grants and 42 published applications in this corpus.
Search patents in C12Y- Granted patents
- 19
- Published applications
- 42
- Assignees
- 22
- Inventors
- 100
- Latest grant
- 2 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 0 | 0 |
| 2008 | 2 | 5 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 2 | 3 |
| 2012 | 2 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 4 |
| 2016 | 0 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of treating cancer using cell based therapies2 Jan 2024US 11,859,208 B2Emory University
- Bone delivery conjugates and method of using same to target proteins to bone15 Feb 2022US 11,248,021 B2Alexion Pharmaceuticals, Inc.
- Bone delivery conjugates and method of using same to target proteins to bone19 Jun 2018US 10,000,532 B2Alexion Pharmaceuticals, Inc.
- Oligonucleotide—containing pharmacological compositions and their use14 Feb 2017US 9,567,584 B2Lakewood Amedex, Inc.
- Recombinant bacterium and uses thereof10 Jan 2017US 9,539,313 B2National Research Council of Canada
- Hair removal by means of detergent/detergent additives containing enzymes24 Jul 2025US 2025/0236818 A1Henkel AG & Co. KGaA
- Targeted degradation and removal of amyloid beta plaques for the prevention and treatment of alzheimer’s diseases via engineered nano-scavenger exosomes13 Mar 2025US 2025/0082775 A1Santa Clara University
- Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies15 Aug 2024US 2024/0271092 A1Emory University
- Pharmaceutical composition for treating alzheimer's disease27 Jul 2023US 2023/0233615 A1Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Methods and compositions for treatment of protein aggregation-based disorders23 Dec 2021US 2021/0395716 A1Valerion Therapeutics, LLC
Most cited
By later US patents
- Bone delivery conjugates and method of using same to target proteins to bone39US 7,763,712 B2Enobia Pharma Inc. · 2010
- Bone delivery conjugates and method of using same to target proteins to bone37US 7,960,529 B2Enobia Pharma Inc. · 2011
- Bone delivery conjugates and method of using same to target proteins to bone29US 10,000,532 B2Alexion Pharmaceuticals, Inc. · 2018
- Method and compositions for promoting osteogenesis25US 7,399,466 B2Enobia Pharma Inc. · 2008
- Composition, methods and reagents for the synthesis of a soluble form of human PHEX23US 6,790,649 B1Universite de Montreal · 2004